CobraTrader13

$SURF Long-Term Target $22.88

Long
NASDAQ:SURF   None
Surface Oncology is a strong company with lots of big pharma ties. Had a brief run-up recently but was rejected by that .786 fib resistance level. Looking to break that level and see major growth this year. Target $22.88 for 182.65%. Like and follow for more biotech ideas :) Happy Trading!
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.